ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Total Knee Arthroplasty (TKA) Cemented Versus Cementless

This study has been completed.

Sponsored by: Hospices Civils de Lyon
Information provided by: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT00132587
  Purpose

The aim of the study is to analyse and to compare the quality of fixation of a femoral implant with or without cement.

One hundred thirty patients will be operated on and included with 2 groups, the first one with TKA all cemented and the second one with TKA with a cementless femoral implant. The study criteria include the IKS (International Knee Society) score and the analysis of a radiolucent line at the femur.

Patients will be reviewed at 2, 6 and 12 months.


Condition Intervention
Osteoarthritis, Knee
Device: cement Palacos R40 and LV40

MedlinePlus related topics:   Knee Replacement    Osteoarthritis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Active Control, Parallel Assignment
Official Title:   Prospective Randomized Study of 130 Total Knee Arthroplasty With Cemented Femoral Implant Versus Cementless

Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:
  • IKS (International Knee Society) score at 12 months

Secondary Outcome Measures:
  • Analysis of femoral radiolucent line at the X-rays (profile and anterior-posterior [AP] view) at 12 months

Estimated Enrollment:   130
Study Start Date:   March 2004
Study Completion Date:   March 2007
Primary Completion Date:   December 2006 (Final data collection date for primary outcome measure)

  Eligibility
Ages Eligible for Study:   50 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Osteoarthritis (medial and/or lateral femoro-tibial arthritis and/or patellofemoral arthritis)
  • Indication of surgical treatment by total knee arthroplasty
  • Age between 50 and 90 years
  • Acceptance and signature to participate

Exclusion Criteria:

  • Rheumatoid or other inflammatory arthritis
  • Association with other surgical procedure (osteotomy)
  • Range of motion inferior to 90°
  • Previous knee surgery (except arthroscopy)
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00132587

Locations
France
Hôpital de la Croix-Rousse    
      Lyon, France, 69317

Sponsors and Collaborators
Hospices Civils de Lyon

Investigators
Principal Investigator:     Philippe NEYRET, MD     Hospices Civils de Lyon    
  More Information


Responsible Party:   Hospices Civils de Lyon ( Philippe Neyret )
Study ID Numbers:   2003.313
First Received:   August 19, 2005
Last Updated:   June 30, 2008
ClinicalTrials.gov Identifier:   NCT00132587
Health Authority:   France: Afssaps - French Health Products Safety Agency

Keywords provided by Hospices Civils de Lyon:
Knee arthroplasty  
Femoral loosening  
Total Knee Arthroplasty  

Study placed in the following topic categories:
Polymethyl Methacrylate
Osteoarthritis, Knee
Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on November 05, 2008




Links to all studies - primarily for crawlers